We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Commentary |

Chronic Kidney Disease and the Public Health Gaps in Evidence From Interventional Trials

Jonathan Himmelfarb, MD
JAMA. 2007;297(23):2630-2633. doi:10.1001/jama.297.23.2630.
Text Size: A A A
Published online


In recent years, chronic kidney disease has received increased attention as a leading public health problem.1 The kidney disease burden, measured in terms of prevalence, associated economic costs, and morbidity, is substantial and increasing. In the United States, more than 400 000 individuals have end-stage renal disease (ESRD),2 for which life can be sustained only with renal replacement therapy such as dialysis or kidney transplantation. In a recent population-based study of US residents 45 years and older, 9.5% had a first-degree relative with ESRD.3 It is estimated that by 2015, more than 700 000 individuals in the United States will have ESRD, and more than 107 000 ESRD-related deaths will occur annually.2 Cardiovascular mortality in patients with ESRD is 10- to 20-fold higher than in the general population and is the leading cause of death.4 Mortality rates for patients with ESRD have shown only modest improvement over the past 2 decades.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

41 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Multidisciplinary approach to calcific uremic arteriolopathy. Curr Opin Nephrol Hypertens 2015;24(6):531-7.